Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria

被引:71
作者
Le Roy, D
Di Padova, F
Adachi, Y
Glauser, MP
Calandra, T
Heumann, D
机构
[1] CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland
[2] Novartis, Pharma Res, Basel, Switzerland
[3] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Tokyo, Japan
关键词
D O I
10.4049/jimmunol.167.5.2759
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
LPS-binding protein (LBP) and CD14 potentiate cell activation by LPS, contributing to lethal endotoxemia. We analyzed the contribution of LBP/CD14 in models of bacterial infection. Mice pretreated with mAbs neutralizing CD14 or LBP showed a delay in TNF-alpha production and died of overwhelming infection within 24 h, after a challenge with 250 CFU of virulent Klebsiella pneumoniae. Blockade of TNF-alpha also increased lethality, whereas pretreatment with TNF-alpha protected mice, even in the presence of LBP and CD14 blockade. Anti-LBP or anti-CD14 mAbs did not improve or decrease lethality with a higher inoculum (10(5) K. pneumoniae) and did not affect outcome following injections of low or high inocula of Escherichia coli O111. These results point to the essential role of LBP/CD14 in innate immunity against virulent bacteria.
引用
收藏
页码:2759 / 2765
页数:7
相关论文
共 35 条
[1]   Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages [J].
Adachi, Y ;
Satokawa, C ;
Saeki, M ;
Ohno, N ;
Tamura, H ;
Tanaka, S ;
Yadomae, T .
JOURNAL OF ENDOTOXIN RESEARCH, 1999, 5 (03) :139-146
[2]   TREATMENT WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROTECTS RATS AGAINST THE LETHALITY, HYPOTENSION, AND HYPOTHERMIA OF GRAM-NEGATIVE SEPSIS [J].
ALEXANDER, HR ;
SHEPPARD, BC ;
JENSEN, JC ;
LANGSTEIN, HN ;
BURESH, CM ;
VENZON, D ;
WALKER, EC ;
FRAKER, DL ;
STOVROFF, MC ;
NORTON, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :34-39
[3]  
BERKOW RL, 1987, J IMMUNOL, V139, P3783
[4]   Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity [J].
Bogdan, C ;
Röllinghoff, M ;
Diefenbach, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :64-76
[5]   PRETREATMENT WITH RECOMBINANT MURINE TUMOR NECROSIS FACTOR ALPHA-CACHECTIN AND MURINE INTERLEUKIN-1 ALPHA PROTECTS MICE FROM LETHAL BACTERIAL-INFECTION [J].
CROSS, AS ;
SADOFF, JC ;
KELLY, N ;
BERNTON, E ;
GEMSKI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :2021-2027
[6]   CHOICE OF BACTERIA IN ANIMAL-MODELS OF SEPSIS [J].
CROSS, AS ;
OPAL, SM ;
SADOFF, JC ;
GEMSKI, P .
INFECTION AND IMMUNITY, 1993, 61 (07) :2741-2747
[7]  
ECHTENACHER B, 1990, J IMMUNOL, V145, P3762
[8]   Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice [J].
Eugster, HP ;
Muller, M ;
Karrer, U ;
Car, BD ;
Schnyder, B ;
Eng, VM ;
Woerly, G ;
LeHir, M ;
diPadova, F ;
Aguet, M ;
Zinkernagel, R ;
Bluethmann, H ;
Ryffel, B .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) :23-36
[9]   LIPOPOLYSACCHARIDE-BINDING PROTEIN AS A MAJOR PLASMA-PROTEIN RESPONSIBLE FOR ENDOTOXEMIC SHOCK [J].
GALLAY, P ;
HEUMANN, D ;
LEROY, D ;
BARRAS, C ;
GLAUSER, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9935-9938
[10]   MODE OF ACTION OF ANTI-LIPOPOLYSACCHARIDE-BINDING PROTEIN ANTIBODIES FOR PREVENTION OF ENDOTOXEMIC SHOCK IN MICE [J].
GALLAY, P ;
HEUMANN, D ;
LEROY, D ;
BARRAS, C ;
GLAUSER, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :7922-7926